Showing results (1451-1460 of 1,689) with videos related to

Sort By:
Pageof 169
European Heart Journal|August 27, 2022
Dapagliflozin for heart failure according to body mass index: the DELIVER trialCarly Adamson, Toru Kondo, Pardeep S Jhund, et al.
European Journal of Heart Failure|December 12, 2018
Heart failure with reduced ejection fraction: comparison of patient characteristics and clinical outcomes within Asia and between Asia, Europe and the AmericasPooja Dewan, Pardeep S Jhund, Li Shen, et al.
Circulation|October 12, 2020
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HFPardeep S Jhund, Scott D Solomon, Kieran F Docherty, et al.
Nature Medicine|August 27, 2022
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVERPardeep S Jhund, Toru Kondo, Jawad H Butt, et al.
Circulation. Heart Failure|May 5, 2022
Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year OutcomesShashank S Sinha, Carolyn M Rosner, Behnam N Tehrani, et al.
Critical Care Explorations|May 31, 2023
Pediatric Swine Model of Methicillin-Resistant Staphylococcus aureus Sepsis-Induced Coagulopathy, Disseminated Microvascular Thrombosis, and Organ InjuriesTrung C Nguyen, Juan C Marini, Bobby Guillory, et al.
Journal of the American College of Cardiology|December 12, 2024
Finerenone, Obesity, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: Prespecified Analysis of FINEARTS-HFJawad H Butt, Alasdair D Henderson, Pardeep S Jhund, et al.
European Journal of Heart Failure|September 29, 2023
Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trialAnkeet S Bhatt, Mikhail N Kosiborod, Brian L Claggett, et al.
Circulation|September 5, 2020
Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HFKieran F Docherty, Pardeep S Jhund, Inder Anand, et al.
JAMA|December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical TrialOrly Vardeny, KyungMann Kim, Jacob A Udell, et al.
Pageof 169